Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02097212
Other study ID # HS#-2794
Secondary ID
Status Completed
Phase N/A
First received March 24, 2014
Last updated March 27, 2017
Start date March 2014
Est. completion date March 2015

Study information

Verified date March 2017
Source National Jewish Health
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators hypothesize that there is a strong correlation between OSA and TBM/HDAC. Our hypothesis is based on the similarities in mechanism (airway collapse), symptoms (daytime and nocturnal dyspnea) predisposing conditions (obesity and neuromuscular abnormalities of the chest wall and the diaphragm), and effect of interventions (CPAP and BIPAP) in these diseases.


Description:

Tracheobronchomalacia (TBM) and HyperDynamic Airway Collapse (HDAC) are two distinct airway diseases that lead to airway collapse which can in turn lead to the symptoms of dyspnea, cough, and inability to expectorate sputum effectively. TBM entails flaccid tracheal and bronchial cartilages leading to airway collapse, emanating primarily from the anterior wall of the lumen. It is seen in conditions such as Relapsing Polychondritis and saber sheath tracheal deformity. HDAC on the other hand is the hyper-flaccidity of the membranous portion of the tracheobronchial tree leading to airway collapse. This condition is commonly seen with obesity and severe emphysema. TBM and HDAC frequently coexist.

In patients with TBM/HDAC sleep disorders are common. Patients often complain of poor quality sleep, snoring, daytime fatigue, and somnolence. These patients are often diagnosed with Obstructive Sleep Apnea (OSA) upon workup.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Females and males ages 18-80 years old

- Able and willing to provide written informed consent

- Existing diagnosis of TBM or HDAC or both

- No pre-existing diagnosis of OSA

- No history of reconstructive surgery of chest wall or diaphragm

Exclusion Criteria:

- Inability to provide informed consent

- Non-English speaking

- Poorly controlled congestive heart failure

- Untreated Insomnia

- Severe Coronary artery disease with active symptoms of angina

- Patient is pregnant, or plans to become pregnant in next 3 months

- Moderate to severe bronchiectasis

- Severe untreated gastroesophageal disease (GERD).

- Moderate to large hiatal hernia deemed to be atleast in part responsible for TBM/HDAC

- Airway obstruction not caused by TBM /HDAC or secondary TBM/HDAC caused by conditions such as Chronic Obstructive Pulmonary Disease (COPD).

- Active or recent (with in last one year) cancer or cancer therapy (chemotherapy, radiation therapy or surgery)

- Inability to properly perform the home sleep test

- Unreliable test data after 2 attempts

- BMI>45

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Jewish Health Denver Colorado

Sponsors (1)

Lead Sponsor Collaborator
National Jewish Health

Country where clinical trial is conducted

United States, 

References & Publications (2)

Majid A, Fernández L, Fernández-Bussy S, Herth F, Ernst A. [Tracheobronchomalacia]. Arch Bronconeumol. 2010 Apr;46(4):196-202. doi: 10.1016/j.arbres.2009.10.011. Epub 2009 Dec 9. Review. Spanish. — View Citation

Murgu SD, Colt HG. Tracheobronchomalacia and excessive dynamic airway collapse. Respirology. 2006 Jul;11(4):388-406. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Epworth Sleepiness Scale The Epworth Sleepiness Scale is widely used in the field of sleep medicine as a subjective measure of a patient's sleepiness. The test is a list of eight situations in which you rate your tendency to become sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing. Baseline
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04939168 - Measuring Atomoxetine and Aroxybutynin In Patients With OSA Phase 2
Completed NCT02908529 - Atomoxetine and Oxybutynin in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT03415633 - Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea N/A
Completed NCT03426631 - DAW1033B2 in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT04206449 - Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA) N/A
Active, not recruiting NCT03018912 - Validating the Use of a Subjectively Reported Sleep Vital Sign N/A
Completed NCT02549508 - Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD N/A
Completed NCT01249924 - The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events N/A
Completed NCT00773721 - Foam Mask - Assessment of Bioburden in a New Mask Seal Material N/A
Completed NCT02314858 - Tailored Treatment to Enhance Risk Perception in Sleep Apnea N/A
Completed NCT01476917 - The ATLAST Long-Term Study Phase 2/Phase 3
Terminated NCT00730041 - Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea Phase 4
Completed NCT00850434 - Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA) N/A
Enrolling by invitation NCT04538755 - DAW2020 on OSA Endotypic Traits Phase 1/Phase 2
Completed NCT02501304 - Feasibility Study of the ReVENT Sleep Apnea System N/A
Withdrawn NCT02805777 - Vent Flow Study of Prototype Nasal CPAP Mask N/A
Active, not recruiting NCT02295306 - Overnight Polysomnography and Respiratory Volume Monitor
Terminated NCT01877928 - Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea N/A
Completed NCT01939938 - Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment N/A
Completed NCT00965783 - Predictors of the Metabolic Effect of Sleep Loss N/A